|
시장보고서
상품코드
2148308
프로그래머블 세포치료 시장 : 세포 유형별, 치료법별, 프로그래밍 기술별, 치료 접근별, 용도별, 최종사용자별, 지역별Programmable Cell Therapy Market, By Cell Type, By Therapy Type, By Programming Technology, By Therapeutic Approach, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
프로그래머블 세포치료 시장은 2026년에 34억 7,000만 달러, 2033년까지는 109억 8,820만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 17.9%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 34억 7,000만 달러 |
| 과거 데이터 대상 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 17.90% | 2033년 시장 규모 예측 : | 109억 8,820만 달러 |
프로그래머블 세포 치료란 T세포, NK세포, 줄기세포, 대식세포 등 유전자가 변형되거나 분자 수준에서 재프로그래밍된 살아있는 세포를 이용하여 병변 세포의 식별 및 파괴와 같은 특정 치료 목적을 달성하는 치료법입니다. 이 분야에서는 합성생물학, CRISPR 기반 유전자 편집, RNA 공학, 그리고 최첨단 세포 제조 기술을 결합하여, 특히 종양학, 자가면역질환, 희귀질환을 대상으로 한 표적 치료법을 개발하고 있습니다.
차세대 세포 치료의 임상 개발, 규제 당국의 동향, 그리고 투자 증가에 힘입어 전 세계 프로그래머블 세포 치료 시장은 성장세를 보이고 있습니다. 정밀 의학의 발전에 따라 프로그래머블 세포 치료는 매우 특이적이고 지속적인 치료 반응을 통해 치료가 어려운 질환을 치료하기 위한 유망한 접근 방식으로 자리 잡고 있습니다.
시장 역학
전 세계 프로그래머블 세포 치료 시장은 세포 프로그래밍의 정확성과 유연성을 높이는 CRISPR-Cas9, 베이스 에디팅, 프라임 에디팅과 같은 유전자 편집 기술의 발전에 힘입어 성장하고 있습니다. 또한, 맞춤형 치료에 대한 수요 증가, 광범위한 임상 개발, 세포 치료에 대한 규제 당국의 승인, 그리고 동종 이식 및 차세대 플랫폼에 대한 투자 확대도 시장 성장을 뒷받침하고 있습니다.
그러나 시장에는 높은 개발 및 치료 비용, 복잡한 제조 공정, 확장성 문제, 엄격한 규제 준수 등 많은 제약 요인이 존재합니다. 그럼에도 불구하고, 확장성과 접근성을 향상시킬 수 있는 동종 유래의 ‘오프 더 쉘프(off-the-shelf)’형 프로그래밍 가능한 세포 치료법 개발에는 큰 기회가 존재합니다. 고형암, 자가면역 질환 및 기타 신흥 치료 분야로의 확대와 더불어, 세포 설계 및 환자 선정에 AI와 머신러닝을 통합함으로써 혁신의 새로운 길을 열어가고 있으며, 프로그래밍 가능한 세포 치료 플랫폼의 개발을 가속화하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설했습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 프로그래머블 세포 치료제 시장의 주요 기업 프로파일을 소개했습니다.
- 본 보고서에서 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 ‘전 세계 프로그래머블 세포 치료 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 프로그래머블 세포 치료 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 프로그래머블 세포치료 시장 : 세포 유형별, 2021년-2033년
제5장 세계의 프로그래머블 세포치료 시장 : 요법 유형별, 2021년-2033년
제6장 세계의 프로그래머블 세포치료 시장 : 프로그래밍 기술별, 2021년-2033년
제7장 세계의 프로그래머블 세포치료 시장 : 치료 접근별, 2021년-2033년
제8장 세계의 프로그래머블 세포치료 시장 : 용도별, 2021년-2033년
제9장 세계의 프로그래머블 세포치료 시장 : 최종사용자별, 2021년-2033년
제10장 세계의 프로그래머블 세포치료 시장 : 지역별, 2021년-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
LSH 26.10.20Programmable Cell Therapy Market is estimated to be valued at USD 3,470.0 Mn in 2026 and is expected to reach USD 10,988.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 17.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3,470.0 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 17.90% | 2033 Value Projection: | USD 10,988.2 Mn |
Programmable cell therapy is the use of genetically modified or molecularly reprogrammed living cells including T cells, NK cells, stem cells and macrophages for defined therapeutic tasks such as identification and destruction of diseased cells. The field combines synthetic biology, CRISPR-based editing of genes, RNA engineering and state-of-the-art cell manufacturing technologies to create targeted treatments, especially for oncology, autoimmune and rare diseases.
The global programmable cell therapy market is gaining momentum, with increased clinical development, regulatory activity and investment in next-generation cell therapies. Programmable cell therapies are becoming a possible approach to treat hard-to-treat diseases through highly specific and durable therapeutic responses due to the development of precision medicine.
Market Dynamics
The global programmable cell therapy market is driven by the advancements in gene-editing technologies such as CRISPR-Cas9, base editing, and prime editing that enhance cell programming precision and flexibility. The growing demand for personalized therapies, extensive clinical development, regulatory approval of cell therapies, and growing investments in allogeneic and next-generation platforms are also supporting the market growth.
However, a number of constraints are present in the market, such as high development and treatment costs, complex manufacturing processes, scalability challenges, and stringent regulatory compliances. Nevertheless, significant opportunities exist within the development of allogeneic, off-the-shelf programmable cell therapies that can improve scalability and accessibility. Expansion into solid tumors, autoimmune and other emerging therapeutic areas, along with the integration of AI and machine learning into cell design and patient selection, is creating new avenues for innovation and accelerating the development of programmable cell therapy platforms.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global programmable cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include CRISPR Therapeutics AG, Senti Biosciences, Inc., Cellectis S.A., Caribou Biosciences, Inc., Allogene Therapeutics, Inc., Century Therapeutics, Inc., Fate Therapeutics, Inc., Sana Biotechnology, Inc., Intellia Therapeutics, Inc., and Cabaletta Bio, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global programmable cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global programmable cell therapy market
Market Segmentation
- Cell Type Insights (Revenue, USD Mn, 2021 - 2033)
- T Cells
- Natural Killer (NK) Cells
- Stem Cells
- Others
- Therapy Type Insights (Revenue, USD Mn, 2021 - 2033)
- CAR-T Cell Therapy
- TCR-T Cell Therapy
- CAR-NK Cell Therapy
- Engineered Stem Cell Therapy
- Others
- Programming Technology Insights (Revenue, USD Mn, 2021 - 2033)
- CRISPR-Based Programming
- Synthetic Gene Circuits
- RNA-Based Programming
- Transcriptional/Protein-Level Programming
- Others
- Therapeutic Approach Insights (Revenue, USD Mn, 2021 - 2033)
- Autologous
- Allogeneic
- In Vivo Cell Programming
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Autoimmune Diseases
- Genetic Disorders
- Infectious Diseases
- Neurological Disorders
- Regenerative Medicine
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Specialty Clinics
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- CRISPR Therapeutics AG
- Senti Biosciences, Inc.
- Cellectis S.A.
- Caribou Biosciences, Inc.
- Allogene Therapeutics, Inc.
- Century Therapeutics, Inc.
- Fate Therapeutics, Inc.
- Sana Biotechnology, Inc.
- Intellia Therapeutics, Inc.
- Cabaletta Bio, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Programmable Cell Therapy Market, By Cell Type
- Global Programmable Cell Therapy Market, By Therapy Type
- Global Programmable Cell Therapy Market, By Programming Technology
- Global Programmable Cell Therapy Market, By Therapeutic Approach
- Global Programmable Cell Therapy Market, By Application
- Global Programmable Cell Therapy Market, By End User
- Global Programmable Cell Therapy Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Manufacturing Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Programmable Cell Therapy Market, By Cell Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- T Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Natural Killer (NK) Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Programmable Cell Therapy Market, By Therapy Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- CAR-T Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- TCR-T Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- CAR-NK Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Engineered Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Programmable Cell Therapy Market, By Programming Technology, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- CRISPR-Based Programming
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Synthetic Gene Circuits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- RNA-Based Programming
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Transcriptional/Protein-Level Programming
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Programmable Cell Therapy Market, By Therapeutic Approach, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Allogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- In Vivo Cell Programming
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Programmable Cell Therapy Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Programmable Cell Therapy Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global Programmable Cell Therapy Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- CRISPR Therapeutics AG
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
- Senti Biosciences, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cellectis S.A.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
- Caribou Biosciences, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allogene Therapeutics, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
- Century Therapeutics, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fate Therapeutics, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sana Biotechnology, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intellia Therapeutics, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cabaletta Bio, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
